The DHCG Live Roundtable: Recap

Written By Jonathan McLeod

The DHC Group hosted a Live Roundtable on May 15, 2025, titled “Data, Privacy, and AI in Pharma”, bringing together industry leaders to discuss the evolving landscape of data privacy and the integration of artificial intelligence (AI) in the pharmaceutical sector. We recapped the webinar below:

Panalist

  • Jonathan McLeod – Throtle

  • Jonathan Zile – PulsePoint

  • Ted Sweetser – PurpleLab

  • Lauren Lawhon – HealthUnion

  • Tyler Doppelheuer – IQVIA

  • Moderator: Alison Tapia (Formerly of Dermavant)

Key Discussion Points

1. Evolving Data Privacy Regulations

The panel explored how regulations like HIPAA and GDPR are reshaping data strategies within the pharmaceutical industry. Emphasis was placed on the importance of compliance and the challenges companies face in adapting to these evolving standards. 

2. Leveraging AI and First-Party Data

Discussions highlighted the potential of AI to drive innovation in pharma, particularly through the use of first-party data. The panelists shared insights on how AI can enhance targeting and customer engagement while maintaining compliance with privacy regulations. 

3. Integrating Diverse Data Sources

The roundtable addressed the complexities of integrating various data sources, including patient and healthcare provider information. Strategies for maintaining data quality and ensuring seamless integration were discussed.  

4. Maintaining Patient Trust

Maintaining patient trust emerged as a critical theme, with conversations focusing on transparency, ethical data use, and the importance of safeguarding patient information in the age of AI. 

5. Ethical AI Deployment

The panelists examined the ethical considerations of deploying AI solutions in pharma, emphasizing the need for responsible AI practices that prioritize patient welfare and data security.

6. Generative AI and Real-Time Analytics

The transformative potential of generative AI and real-time analytics was a focal point, with discussions on how these technologies can revolutionize targeting strategies and customer engagement in a privacy-first landscape.

This roundtable provided valuable insights into the intersection of data privacy and AI in pharma, highlighting both the opportunities and challenges that lie ahead as the industry navigates this complex landscape.

Jonathan McLeod
Next

Why Deterministic Identity Can Scale Healthcare Marketing